Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by TriumphSpitSixon Aug 18, 2020 3:02am
215 Views
Post# 31421343

RE:RE:RE:This is good!

RE:RE:RE:This is good!Of course it would be a huge benefit. It would increase the kinds of cancers they can treat which are currently "out of range" due to the 3-4 inch maximum penetration of laser light.

Hankerchief wrote:
robertshaw wrote:
Hankerchief wrote:
The Company is planning to commence toxicology studies withRutherrin® to determine the maximum recommended human doseof the drug, when administered systemically into the human body,via intravenous injections. Due to the limitations of using laser light to activate Rutherrin® indeep oncological targets, Theralase’s research strongly suggeststhat Rutherrin® may be activated with radiation therapy, which isable to increase the ‘tumour’s damage zone’ and the effectivenessof the anti-cancer therapy beyond the reach of light in the body.


Finally something about actually making progress with IV Rutherrin and xray activation!!  "Planning to commence" needs to be soon, very soon IMO.


But the idiot management has a history to call more than 3 years as "immediate future"



Yep.  Maybe this time will be different.  I really think the IV + Xray activation could really be a huge benefit.



<< Previous
Bullboard Posts
Next >>